로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Tau-441

Tau-441

요약

Name:Microtubule-associated protein tau
Target Synonym:MAPT,MTBT1,Paired helical filament-tau,MAPTL,Microtubule Associated Protein Tau,G Protein Beta1/Gamma2 Subunit-Interacting Factor 1,Protein Phosphatase 1, Regulatory Subunit 103,Neurofibrillary Tangle Protein,PHF-Tau,TAU,Microtubule-Associated Protein Tau, Isoform 4,Microtubule-Associated Protein Tau,PPP1R103,FTDP-17,MTBT2,DDPAC,MSTD,PPND,tau Proteins,MGC138549,FLJ31424
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:31
Lastest Research Phase:Approved

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*

사용자 리뷰

Synonym Name

DDPAC,FTDP-17,MAPT,MSTD,MTBT1,Tau,PHF-tau,TAU

Background

Tau is a microtubule-associated protein, which encodes by the MAPT gene that located on chromosome 17q21. Tau Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. Hyperphosphorylation of the tau protein (tau inclusions, pTau) can result in the self-assembly of tangles of paired helical filaments and straight filaments, which are involved in the pathogenesis of Alzheimer's disease, frontotemporal dementia, and other tauopathies. Tau-441 is known as "2N4R," "Isoform Tau-F," "Tau-4" or "Tau 441", which consisting of 441 amino acid. Tau-441 is a potential therapeutic target for pathogenesis.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Flortaucipir F 18 F-18-AV-1451; 18F-AV-1451; T807 Approved Siemens Medical Solution Tauvid United States Alzheimer Disease Avid Radiopharmaceuticals Inc 2020-05-28 Supranuclear Palsy, Progressive; Brain Injuries; Brain Injuries, Traumatic; Depression; Brain Concussion; Aphasia, Primary Progressive; Chronic Traumatic Encephalopathy; Pick Disease of the Brain; Alzheimer Disease; Cognitive Dysfunction; Tauopathies; Dementia; Parkinson Disease; Frontotemporal Dementia; Cognition Disorders; Neurodegenerative Diseases Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
APN-1701 [18F]AM-PBB3; 18F-AM-PBB3; APN-1701 Phase 2 Clinical National Institute Of Radiological Sciences, Aprinoia Therapeutics Ltd Nerve Degeneration; Alzheimer Disease Details
MC-1 (Lilly) MC-1 (Lilly) Phase 1 Clinical Eli Lilly And Company Alzheimer Disease Details
11C-PBB3 11C-PBB3 Clinical National Institute Of Radiological Sciences Alzheimer Disease Details
[18F]THK-5105 [18F]THK-5105 Phase 2 Clinical Tohoku University Alzheimer Disease Details
[18F]THK-5117 [18F]THK-5117 Phase 2 Clinical Tohoku University Alzheimer Disease Details
ASN-120290 ASN-120290; ASN-561; ASN-90 Phase 1 Clinical Merck Serono Alzheimer Disease Details
ReS19-T ReS19-T Phase 1 Clinical Remynd Alzheimer Disease Details
TRx-0037 TRx-0037 Taurx Pharmaceuticals Details
Alzheimer's disease vaccine (Axon Neuroscience) AADvac-1 Axon Biochemicals Details
BMS-241027 BMS-241027 Bristol-Myers Squibb Company Details
Leuco methylthioninium L-MTx; LMT-X; TRX-0237; Leuco-MTx; LMTM Phase 1 Clinical Taurx Pharmaceuticals Cognitive Dysfunction; Alzheimer Disease Details
E-2814 E-2814 Eisai Co Ltd Details
Zagotenemab LY-3303560 Eli Lilly And Company Details
APNmAb-005 APNmAb-005 Phase 1 Clinical Aprinoia Therapeutics Ltd Nerve Degeneration; Alzheimer Disease; Tauopathies Details
[18F]GTP-1 [18F]GTP-1 Phase 2 Clinical Genentech Inc Alzheimer Disease Details
Lu-AF87908 Lu-AF87908; Lu-AF-87908 Phase 1 Clinical H. Lundbeck A/S Alzheimer Disease Details
Buntanetap ANVS-405; ANVS-401 Phase 3 Clinical Raptor Pharmaceutical Down Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Cognitive Dysfunction; Parkinson Disease; Frontotemporal Dementia Details
BEY-2153 BEY-2153 Phase 1 Clinical Beyondbio Inc Alzheimer Disease Details
PNT-001 PNT-001 Phase 1 Clinical Pinteon Therapeutics Inc Brain Injuries, Traumatic; Alzheimer Disease Details
Protollin Phase 1 Clinical Brigham and Women's Hospital Inc Alzheimer Disease Details
ACI-35.030 ACI-35.030; ACI-35 Phase 2 Clinical Ac Immune Sa Brain Diseases; Cognitive Dysfunction; Alzheimer Disease; Tauopathies; Dementia; Central Nervous System Diseases Details
NIO-752 NIO-752 Phase 1 Clinical Novartis Pharma Ag Supranuclear Palsy, Progressive; Alzheimer Disease; Cognitive Dysfunction; Neurodegenerative Diseases Details
Mecripyrine Hydrochloride SCR-1693; Y-1A Phase 1 Clinical Jiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, Nanjing Ningdan New Drug Technology Co Ltd Alzheimer Disease Details
ISIS-814907 BIIB-080; ISIS-814907; IONIS-MAPTRx; ISIS-BIIB4Rx; IONIS-BIIB4RX Phase 2 Clinical Biogen Inc, Ionis Pharmaceuticals Inc Alzheimer Disease; Cognitive Dysfunction Details
Izaflortaucipir F-18 [18F]PI-2620; PI-2620; 18F-PI-2620 Phase 3 Clinical Piramal, Ac Immune Sa Hypotension; Supranuclear Palsy, Progressive; Brain Concussion; Frontotemporal Lobar Degeneration; Alzheimer Disease; Cognitive Dysfunction Details
MK-2214 MK-2214 Phase 1 Clinical Merck Sharp & Dohme LLC Alzheimer Disease Details
Tilavonemab C2N-8E12; ABBV-8E12 Phase 2 Clinical C2n Diagnostics Llc Supranuclear Palsy, Progressive; Alzheimer Disease Details
Bepranemab UCB-0107 Phase 2 Clinical Ucb Supranuclear Palsy, Progressive; Alzheimer Disease Details
PRX-005 PRX-005 Phase 1 Clinical Prothena Alzheimer Disease; Frontotemporal Dementia; Amyotrophic Lateral Sclerosis; Neurodegenerative Diseases Details
Posdinemab JNJ-63733657; JNJ-3657 Phase 2 Clinical Janssen Global Services Llc Cognitive Dysfunction; Alzheimer Disease; Dementia Details
APN-1607 [18F]MNI-958; APN-0000455; F0-PBB3; PM-PBB3; APN-1607; 18F-PM-PBB3; [18F]PM-PBB3; 18F-APN-1607; [18F]APN-1607 Phase 3 Clinical Aprinoia Therapeutics Ltd Supranuclear Palsy, Progressive; Nerve Degeneration; Alzheimer Disease; Cognitive Dysfunction; Diagnostic agents; Cognition Disorders Details

This web search service is supported by Google Inc.

totop